Deepak Kumar Sahel

461 total citations
22 papers, 303 citations indexed

About

Deepak Kumar Sahel is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Deepak Kumar Sahel has authored 22 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Biomaterials and 3 papers in Cancer Research. Recurrent topics in Deepak Kumar Sahel's work include RNA Interference and Gene Delivery (8 papers), CRISPR and Genetic Engineering (8 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Deepak Kumar Sahel is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), CRISPR and Genetic Engineering (8 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Deepak Kumar Sahel collaborates with scholars based in India, United States and United Kingdom. Deepak Kumar Sahel's co-authors include Deepak Chitkara, Anupama Mittal, Saurabh Sharma, Vivek Singh, Dharmendra Kumar Khatri, Rajeev Sakhuja, Lalitkumar K. Vora, Mohd Azhar, Indumathi Mariappan and Rohan Ghadi and has published in prestigious journals such as Nature Communications, Nature Biotechnology and Journal of Controlled Release.

In The Last Decade

Deepak Kumar Sahel

20 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak Kumar Sahel India 12 182 64 56 32 26 22 303
Mengjun Zhang China 8 219 1.2× 63 1.0× 61 1.1× 23 0.7× 60 2.3× 14 342
Katherine E. Rogers United States 4 169 0.9× 77 1.2× 82 1.5× 29 0.9× 25 1.0× 7 317
Pranjali Kanvinde United States 8 97 0.5× 63 1.0× 55 1.0× 62 1.9× 10 0.4× 9 307
Rowshan Ara Islam Malaysia 8 197 1.1× 81 1.3× 56 1.0× 36 1.1× 40 1.5× 11 349
Naitik Jain India 12 143 0.8× 114 1.8× 104 1.9× 23 0.7× 33 1.3× 29 328
Andrew Martin United States 5 183 1.0× 34 0.5× 33 0.6× 16 0.5× 16 0.6× 6 306
Vanessa Bourgeaux France 11 158 0.9× 44 0.7× 63 1.1× 8 0.3× 14 0.5× 21 350
Laetitia Vanwonterghem France 11 178 1.0× 95 1.5× 95 1.7× 21 0.7× 23 0.9× 13 337
Natalia García‐Aranda Spain 9 99 0.5× 119 1.9× 77 1.4× 18 0.6× 20 0.8× 12 279
Rasmus Eliasen Denmark 10 229 1.3× 118 1.8× 114 2.0× 18 0.6× 26 1.0× 15 412

Countries citing papers authored by Deepak Kumar Sahel

Since Specialization
Citations

This map shows the geographic impact of Deepak Kumar Sahel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Kumar Sahel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Kumar Sahel more than expected).

Fields of papers citing papers by Deepak Kumar Sahel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Kumar Sahel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Kumar Sahel. The network helps show where Deepak Kumar Sahel may publish in the future.

Co-authorship network of co-authors of Deepak Kumar Sahel

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Kumar Sahel. A scholar is included among the top collaborators of Deepak Kumar Sahel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Kumar Sahel. Deepak Kumar Sahel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jozić, Antony, Ju‐Hyun Kim, Mathieu Berchel, et al.. (2026). In vivo endosomal escape assay identifies mechanisms for efficient hepatic LNP delivery. Nature Biotechnology.
2.
Vlasova, Kseniya Yu., Nathan D. Pennock, Antony Jozić, et al.. (2025). Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing. Nature Communications. 16(1). 4021–4021. 6 indexed citations
3.
Sahel, Deepak Kumar, Nathan D. Pennock, Antony Jozić, et al.. (2025). Improved localized mRNA delivery using lipid nanoparticles with a novel synthetic cholesterol derivative. PubMed. 3(1). 187–197.
4.
Sahel, Deepak Kumar, et al.. (2025). Enhancing temozolomide in vivo stability and efficacy through hybrid nanoconjugate approach for improved glioblastoma multiforme treatment. Asian Journal of Pharmaceutical Sciences. 20(3). 101022–101022. 2 indexed citations
5.
Sahel, Deepak Kumar, Vivek Singh, Manu Dalela, et al.. (2024). cRGD-modified hybrid lipopolymeric nanoplexes for gene editing in the posterior segment of the eye. International Journal of Biological Macromolecules. 271(Pt 2). 132426–132426. 4 indexed citations
6.
Sahel, Deepak Kumar, et al.. (2024). Lipo-polymeric nano-complexes for dermal delivery of a model protein. RSC Advances. 14(28). 20351–20364. 2 indexed citations
7.
Sahel, Deepak Kumar, et al.. (2024). Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects. RSC Advances. 14(44). 32411–32435. 17 indexed citations
8.
Sahel, Deepak Kumar, Lalitkumar K. Vora, Aishwarya Saraswat, et al.. (2023). CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective. Advanced Science. 10(19). e2207512–e2207512. 46 indexed citations
9.
Sahel, Deepak Kumar, et al.. (2023). Topical delivery of Anti-VEGF nanomedicines for treating psoriasis. Journal of Drug Delivery Science and Technology. 83. 104365–104365. 1 indexed citations
10.
Sahel, Deepak Kumar, et al.. (2023). Temozolomide-fatty acid conjugates for glioblastoma multiforme: In vitro and in vivo evaluation. Journal of Controlled Release. 359. 161–174. 15 indexed citations
11.
Sahel, Deepak Kumar, et al.. (2023). Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid. Macromolecular Rapid Communications. 44(14). e2300101–e2300101. 3 indexed citations
12.
Singh, Vijay Kumar, et al.. (2022). New Frontier in the Management of Corneal Dystrophies: Basics, Development, and Challenges in Corneal Gene Therapy and Gene Editing. Asia-Pacific Journal of Ophthalmology. 11(4). 346–359. 9 indexed citations
13.
Sahel, Deepak Kumar, et al.. (2022). Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme. Journal of Controlled Release. 350. 494–513. 30 indexed citations
14.
Sahel, Deepak Kumar, et al.. (2022). Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities. Asian Journal of Pharmaceutical Sciences. 17(2). 153–176. 25 indexed citations
15.
Sahel, Deepak Kumar, et al.. (2022). Coenzyme Q10 loaded lipid-polymer hybrid nanoparticles in gel for the treatment of psoriasis like skin condition. Journal of Drug Delivery Science and Technology. 76. 103672–103672. 12 indexed citations
16.
Sahel, Deepak Kumar, Mohd Azhar, Vivek Singh, et al.. (2022). Cationic lipopolymeric nanoplexes containing the CRISPR/Cas9 ribonucleoprotein for genome surgery. Journal of Materials Chemistry B. 10(37). 7634–7649. 7 indexed citations
17.
Sharma, Saurabh, et al.. (2021). Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment. Materials Science and Engineering C. 128. 112305–112305. 28 indexed citations
18.
Sharma, Saurabh, Deepak Kumar Sahel, Manu Dalela, et al.. (2020). Folate-Targeted Cholesterol-Grafted Lipo-Polymeric Nanoparticles for Chemotherapeutic Agent Delivery. AAPS PharmSciTech. 21(7). 280–280. 21 indexed citations
19.
Sahel, Deepak Kumar, Anupama Mittal, & Deepak Chitkara. (2019). CRISPR/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool. Journal of Pharmacology and Experimental Therapeutics. 370(3). 725–735. 32 indexed citations
20.
Sahel, Deepak Kumar, et al.. (2019). Scalable Self-Assembling Micellar System for Enhanced Oral Bioavailability and Efficacy of Lisofylline for Treatment of Type-I Diabetes. Molecular Pharmaceutics. 16(12). 4954–4967. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengjun Zhang Breakdown of academic impact, for papers by Katherine E. Rogers Breakdown of academic impact, for papers by Pranjali Kanvinde Breakdown of academic impact, for papers by Rowshan Ara Islam Breakdown of academic impact, for papers by Naitik Jain Breakdown of academic impact, for papers by Andrew Martin Breakdown of academic impact, for papers by Vanessa Bourgeaux Breakdown of academic impact, for papers by Laetitia Vanwonterghem Breakdown of academic impact, for papers by Natalia García‐Aranda Breakdown of academic impact, for papers by Rasmus Eliasen
Rankless by CCL
2026